Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial

BACKGROUND: Kidneys from deceased donors are being used to meet the growing need for grafts. However, delayed graft function (DGF) and acute rejection incidences are high, leading to adverse effects on graft outcomes. Optimal induction intervention should include both renal structure injury repair a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Transl Med
Main Authors: Sun, Qipeng, Huang, Zhengyu, Han, Fei, Zhao, Ming, Cao, Ronghua, Zhao, Daqiang, Hong, Liangqing, Na, Ning, Li, Heng, Miao, Bin, Hu, Jianmin, Meng, Fanhang, Peng, Yanwen, Sun, Qiquan
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5842532/
https://ncbi.nlm.nih.gov/pubmed/29514693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-018-1422-x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki